BIOCONPharmaceuticals
Biocon Ltd — Profit & Loss Statement
₹360.90
-2.52%
Biocon Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 253.39 Cr | 155.53 Cr | -14.97 Cr | -21.91 Cr | — |
| Tax Rate For Calcs | 0.23 | 0.15 | 0.15 | 0.22 | — |
| Normalized EBITDA | 3.36K Cr | 3.03K Cr | 2.53K Cr | 1.96K Cr | — |
| Total Unusual Items | 1.10K Cr | 1.04K Cr | -99.80 Cr | -99.60 Cr | — |
| Total Unusual Items Excluding Goodwill | 1.10K Cr | 1.04K Cr | -99.80 Cr | -99.60 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 1.01K Cr | 1.02K Cr | 462.70 Cr | 648.40 Cr | — |
| Reconciled Depreciation | 1.69K Cr | 1.57K Cr | 1.11K Cr | 814.20 Cr | — |
| Reconciled Cost Of Revenue | 5.20K Cr | 4.91K Cr | 3.67K Cr | 2.72K Cr | — |
| EBITDA | 4.46K Cr | 4.07K Cr | 2.43K Cr | 1.86K Cr | — |
| EBIT | 2.77K Cr | 2.50K Cr | 1.32K Cr | 1.05K Cr | — |
| Net Interest Income | -788.70 Cr | -813.10 Cr | -306.60 Cr | 44.50 Cr | — |
| Interest Expense | 887.70 Cr | 974.40 Cr | 419.00 Cr | 67.60 Cr | — |
| Interest Income | 108.70 Cr | 161.30 Cr | 112.40 Cr | 112.10 Cr | — |
| Normalized Income | 164.99 Cr | 141.13 Cr | 547.53 Cr | 726.09 Cr | — |
| Net Income From Continuing And Discontinued Operation | 1.01K Cr | 1.02K Cr | 462.70 Cr | 648.40 Cr | — |
| Total Expenses | 13.43K Cr | 12.76K Cr | 9.31K Cr | 6.84K Cr | — |
| Rent Expense Supplemental | 19.50 Cr | 0.30 Cr | 2.90 Cr | 3.80 Cr | — |
| Diluted Average Shares | 119.82 Cr | 119.69 Cr | 119.59 Cr | 119.64 Cr | — |
| Basic Average Shares | 119.75 Cr | 119.54 Cr | 119.31 Cr | 119.11 Cr | — |
| Diluted EPS | 8.46 | 8.54 | 3.87 | 5.42 | — |
| Basic EPS | 8.46 | 8.55 | 3.88 | 5.44 | — |
| Diluted NI Availto Com Stockholders | 1.01K Cr | 1.02K Cr | 462.70 Cr | 648.40 Cr | — |
| Net Income Common Stockholders | 1.01K Cr | 1.02K Cr | 462.70 Cr | 648.40 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 1.01K Cr | 1.02K Cr | 462.70 Cr | 648.40 Cr | — |
| Minority Interests | -416.10 Cr | -275.30 Cr | -180.30 Cr | -123.20 Cr | — |
| Net Income Including Noncontrolling Interests | 1.43K Cr | 1.30K Cr | 643.00 Cr | 771.60 Cr | — |
| Net Income Continuous Operations | 1.43K Cr | 1.30K Cr | 643.00 Cr | 771.60 Cr | — |
| Tax Provision | 457.20 Cr | 227.40 Cr | 254.10 Cr | 211.50 Cr | — |
| Pretax Income | 1.89K Cr | 1.53K Cr | 897.10 Cr | 983.10 Cr | — |
| Other Non Operating Income Expenses | 1.10 Cr | 3.40 Cr | 3.90 Cr | 0.70 Cr | — |
| Special Income Charges | 1.14K Cr | 866.80 Cr | -80.60 Cr | -84.30 Cr | — |
| Other Special Charges | -1.15K Cr | -867.90 Cr | 79.60 Cr | 83.50 Cr | — |
| Write Off | 3.00 Cr | 1.10 Cr | 1.00 Cr | 0.80 Cr | — |
| Net Non Operating Interest Income Expense | -788.70 Cr | -813.10 Cr | -306.60 Cr | 44.50 Cr | — |
| Total Other Finance Cost | 9.70 Cr | — | — | — | — |
| Interest Expense Non Operating | 887.70 Cr | 974.40 Cr | 419.00 Cr | 67.60 Cr | — |
| Interest Income Non Operating | 108.70 Cr | 161.30 Cr | 112.40 Cr | 112.10 Cr | — |
| Operating Income | 1.63K Cr | 1.43K Cr | 1.63K Cr | 1.19K Cr | — |
| Operating Expense | 8.23K Cr | 7.85K Cr | 5.64K Cr | 4.11K Cr | — |
| Other Operating Expenses | 1.66K Cr | 2.21K Cr | 1.59K Cr | 939.90 Cr | — |
| Depreciation And Amortization In Income Statement | 1.69K Cr | 1.57K Cr | 1.11K Cr | 814.20 Cr | — |
| Amortization | 685.90 Cr | 629.50 Cr | 291.40 Cr | 131.00 Cr | — |
| Depreciation Income Statement | 1.00K Cr | 939.30 Cr | 821.70 Cr | 683.20 Cr | — |
| Research And Development | 634.10 Cr | 712.30 Cr | 489.80 Cr | 191.90 Cr | — |
| Selling General And Administration | 1.27K Cr | 886.00 Cr | 486.70 Cr | 430.70 Cr | — |
| Selling And Marketing Expense | 649.90 Cr | 296.60 Cr | 221.60 Cr | 243.80 Cr | — |
| General And Administrative Expense | 622.10 Cr | 589.40 Cr | 265.10 Cr | 186.90 Cr | — |
| Rent And Landing Fees | 19.50 Cr | 0.30 Cr | 2.90 Cr | 3.80 Cr | — |
| Gross Profit | 9.85K Cr | 9.29K Cr | 7.27K Cr | 5.30K Cr | — |
| Cost Of Revenue | 5.20K Cr | 4.91K Cr | 3.67K Cr | 2.72K Cr | — |
| Total Revenue | 15.05K Cr | 14.20K Cr | 10.93K Cr | 8.02K Cr | — |
| Operating Revenue | 15.05K Cr | 14.20K Cr | 10.93K Cr | 8.02K Cr | — |
| Net Income Discontinuous Operations | — | — | — | — | -9.70 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Biocon Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.